Nucleic acid recognition, through activation of IRF3, is able to induce protein phase separation and the formation of membraneless organelles and can detect NF2m-IRF3 condensates in patients with neurofibromatosis type 2 [125]. The gene discussed is IRF3; the disease is NF2-related schwannomatosis.